IRLAB Therapeutics | Investing in Life Science 2024 скачать в хорошем качестве

IRLAB Therapeutics | Investing in Life Science 2024

Kristina Torfgård, CEO of IRLAB Therapeutics, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide the funds. From early-stage investments, where business angels and seed investors drive medical breakthroughs, to growth-stage investments empowering promising ventures to become ready for partnering and/or fueling market expansion and later-stage strategic investments accelerating growth and facilitating a global market presence. The “Investing in life science: From seed to success” event catered to life science companies in all development stages, who gained insight from investors in the various life cycle stages, simultaneously providing investors a chance to pick the brains of peers, engage in thought-provoking discussions and meet life science companies in early-to-commercial stages. Subscribe and follow BioStock on: YouTube https://bit.ly/Biostock LinkedIn:   / biostock   Facebook:   / biostock.se   https://www.biostock.se/ #BioStock #LifeScience #IRLAB About BioStock BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies